Tumor Microenvironment

6 researchers across 2 institutions

6 Researchers
2 Institutions
0 Grant PIs
0 High Impact

Research into the tumor microenvironment investigates the complex ecosystem of cells, blood vessels, and biochemicals that surround and support a tumor's growth and spread. This work examines how non-cancerous cells, such as fibroblasts, immune cells, and endothelial cells, interact with malignant cells. Studies employ molecular biology techniques, advanced imaging, and in vitro models to understand these interactions, aiming to identify vulnerabilities and develop new therapeutic strategies. Key areas of focus include the role of inflammation in cancer progression and the development of resistance to therapies.

In Arkansas, understanding the tumor microenvironment holds particular relevance for public health initiatives addressing cancer disparities. Research in this area can inform the development of novel treatments and diagnostic tools that may benefit Arkansans, a significant portion of whom are affected by cancer. Furthermore, advancements in this field have the potential to foster growth in the state's biotechnology and pharmaceutical sectors by supporting the development of new cancer therapies and diagnostic technologies.

This research area draws on expertise from molecular biology, immunology, and pharmacology. It is supported by collaborations across institutions within Arkansas, facilitating a comprehensive approach to understanding and targeting the tumor microenvironment.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Mulu Z. Tesfay UAMS 8 437
Shelby N. Bess University of Arkansas 5 54
Khandoker Usran Ferdous UAMS 4 58
Alric Fernandes University of Arkansas 2 12
Davin Means University of Arkansas 1 8
April Jules University of Arkansas 1 8

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
10,975 works in 2025
+7.1% CAGR 2018–2025
Leadership concentration
3.5% held by global top 5 institutions
Fragmented HHI 9
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2025 window.

Top US institutions in this area

  1. 1 The University of Texas MD Anderson Cancer Center 2,705
  2. 2 National Cancer Institute 1,738
  3. 3 Harvard University 1,664
  4. 4 University of California San Diego 1,446
  5. 5 Memorial Sloan Kettering Cancer Center 1,360

Cross-Institution Connections

Researchers at different institutions with overlapping expertise in Tumor Microenvironment.

Shelby N. Bess University of Arkansas
33%
Browse All 6 Researchers in Directory